Tilray Brands, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

Company Performance - Tilray Brands, Inc. (TLRY) closed at $7.75, reflecting a -1.77% change from the previous day, underperforming the S&P 500's gain of 0.69% [1] - Over the past month, shares of Tilray have decreased by 13.58%, while the Medical sector gained 0.77% and the S&P 500 lost 1% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with an expected EPS of -$0.14, indicating an 86% growth compared to the same quarter last year [2] - Revenue is projected at $205.93 million, reflecting a 10.85% increase from the equivalent quarter last year [2] Annual Forecast - For the entire year, the Zacks Consensus Estimates forecast an EPS of -$0.56 and revenue of $871.99 million, indicating changes of -660% and +6.17% respectively compared to the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for Tilray reflect shifting short-term business dynamics, with positive revisions indicating optimism about the business outlook [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Tilray Brands, Inc. at 3 (Hold) [6] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 148, placing it in the bottom 40% of over 250 industries [7] - Research indicates that top-rated industries outperform the bottom half by a factor of 2 to 1 [7]